207_Combined course Presentations

First page Table of contents Previous page 140 Next page Last page

Increase in pCR

Increase in pCR

74%

65%

Long CHT + dual anti-HER2 therapy Long CHT +Trastuzumab similar to short CHT+dual anti- HER2

48%

45%

38%

25%

Short CHT +Trastuzumab

20%

15%

CHT alone

Made with